Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Amin Alousi"'
Autor:
Rima M. Saliba, Stephanie J. Lee, Paul A Carpenter, Geoffrey R Hill, Catherine J. Lee, Amin Alousi, May Daher, George Chen, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/175caaed64d4459882226f3e5d22b641
Autor:
Guillaume Richard-Carpentier, Caitlin R. Rausch, Koji Sasaki, Danielle Hammond, Kiyomi Morita, Koichi Takahashi, Guilin Tang, Rashmi Kanagal-Shamanna, Kapil Bhalla, Courtney D. Dinardo, Gautam Borthakur, Naveen Pemmaraju, Elizabeth J. Shpall, Amin Alousi, Naval G. Daver, Guillermo Garcia-Manero, Marina Y. Konopleva, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Acute myeloid leukemia (AML) with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) has a very poor prognosis. Determinants of clinical outcomes and optimal treatment remain uncertain. We retrospectively reviewed 108 cases of AML with inv(3)/t(3;3) and evaluated cl
Externí odkaz:
https://doaj.org/article/669bea5eeb2740ed9b7b6723c8758904
Autor:
Rohtesh S. Mehta, David Marin, Amin Alousi, Christopher G. Kanakry, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Kristin Page, Shahinaz M. Gadalla, Daniel Weisdorf, Partow Kebriaei
Publikováno v:
Blood Advances. 7:1594-1603
Haploidentical hematopoietic cell transplantation (HCT) with posttransplant cyclophosphamide (PTCy) graft-versus-host-disease (GVHD) prophylaxis yields a similar overall survival (OS) to HLA-matched unrelated donor (MUD) HCT with conventional prophyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::086d5eb0a9244407a2b16eac6baf9e3f
https://doi.org/10.1182/bloodadvances.2022009240
https://doi.org/10.1182/bloodadvances.2022009240
Autor:
Yago Nieto, Stephen Gruschkus, Benigno C. Valdez, Roy B. Jones, Paolo Anderlini, Chitra Hosing, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Amin Alousi, Neeraj Saini, Samer Srour, Katayoun Rezvani, Jeremy Ramdial, Melissa Barnett, Alison Gulbis, Terri Lynn Shigle, Sairah Ahmed, Swaminathan Iyer, Hun Lee, Ranjit Nair, Simrit Parmar, Raphael Steiner, Bouthaina Dabaja, Chelsea Pinnix, Jillian Gunther, Branko Cuglievan, Kris Mahadeo, Sajad Khazal, Hubert Chuang, Richard Champlin, Elizabeth J. Shpall, Borje S. Andersson
Publikováno v:
Haematologica, Vol 107, Iss 4 (2021)
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal. We retrospectively analyzed a
Externí odkaz:
https://doaj.org/article/20d140bbdb7c4c2e996502cd045e920c
Autor:
Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundCOVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific antibodies found in CCP.Patients and MethodsPatients
Externí odkaz:
https://doaj.org/article/e8c03ca534d6409a85e0928d9fbecfca
Autor:
Rima M. Saliba, Lauren Veltri, Gabriela Rondon, Julianne Chen, Gheath Al-Atrash, Amin Alousi, Charles Martinez, LaJerald Augustine, Chitra M. Hosing, Betul Oran, Katayoun Rezvani, Elisabeth J. Shpall, Partow Kebriaei, Issa F. Khouri, Uday Popat, Richard E. Champlin, Stefan O. Ciurea
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/718cb27c5d4e49b7ac82c530b9609a83
Autor:
Shernan G. Holtan, Todd E. DeFor, Angela Panoskaltsis-Mortari, Nandita Khera, John E. Levine, Mary E.D. Flowers, Stephanie J. Lee, Yoshihiro Inamoto, George L. Chen, Sebastian Mayer, Mukta Arora, Jeanne Palmer, Corey S. Cutler, Sally Arai, Aleksandr Lazaryan, Laura F. Newell, Madan H. Jagasia, Iskra Pusic, William A. Wood, Anne S. Renteria, Gregory Yanik, William J. Hogan, Elizabeth Hexner, Francis Ayuk, Ernst Holler, Udomsak Bunworasate, Yvonne A. Efebera, James L.M. Ferrara, Joseph Pidala, Alan Howard, Juan Wu, Javier Bolaños-Meade, Vincent Ho, Amin Alousi, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan
Publikováno v:
Blood Advances, Vol 2, Iss 15, Pp 1882-1888 (2018)
Abstract: Amphiregulin (AREG) is an epidermal growth factor receptor ligand that can restore integrity to damaged intestinal mucosa in murine models of acute graft-versus-host disease (aGVHD). We previously reported that circulating AREG is elevated
Externí odkaz:
https://doaj.org/article/62b07f277f2a424b9ff256dc967ca02c
Autor:
Aaron Etra, Alexandra Capellini, Amin Alousi, Monzr M. Al Malki, Hannah Choe, Zachariah DeFilipp, William J. Hogan, Carrie L. Kitko, Francis Ayuk, Janna Baez, Isha Gandhi, Stelios Kasikis, Sigrun Gleich, Elizabeth Hexner, Matthias Hoepting, Urvi Kapoor, Steven Kowalyk, Deukwoo Kwon, Amelia Langston, Marco Mielcarek, George Morales, Umut Özbek, Muna Qayed, Ran Reshef, Wolf Rösler, Nikolaos Spyrou, Rachel Young, Yi-Bin Chen, James L. M. Ferrara, John E. Levine
Publikováno v:
Blood. 140:1867-1869
The standard primary treatment for acute graft-versus-host disease (GVHD) requires prolonged, high-dose systemic corticosteroids (SCSs) that delay reconstitution of the immune system. We used validated clinical and biomarker staging criteria to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a315ad0a5c81a247666a83b7d4a9c84b
https://doi.org/10.1182/blood-2022-156000
https://doi.org/10.1182/blood-2022-156000
Autor:
Rohtesh S. Mehta, Jeremy Ramdial, David Marin, Amin Alousi, Christopher G. Kanakry, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Kristin Page, Shahinaz M. Gadalla, Partow Kebriaei, Daniel Weisdorf
Publikováno v:
Transplantation and Cellular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36b7b9f411d68fed45735be104339315
https://doi.org/10.1016/j.jtct.2023.03.028
https://doi.org/10.1016/j.jtct.2023.03.028
Autor:
Robert Jenq, Eiko Hayase, Tomo Hayase, Akash Mukherjee, Stuart Stinson, Mohamed Jamal, Miriam Ortega, Christopher Sanchez, Saira Ahmed, Jennifer Karmouch, Chia-Chi Chang, Ivonne Flores, Lauren McDaniel, Alexandria Brown, Rawan El-Himri, Valerie Chapa, Lin Tan, Bao Tran, Dung Pham, Taylor Halsey, Yimei Jin, Wen-Bin Tsai, Rishika Prasad, Israel Glover, Nadim Ajami, Jennifer Wargo, Samuel Shelburne, Pablo Okhuysen, Chen Liu, Stephanie Fowler, Margaret Conner, Christine Peterson, Gabriela Rondon, Jeffrey J Molldrem, Richard Champlin, Elizabeth Shpall, Philip Lorenzi, Rohtesh Mehta, Eric Martens, Amin Alousi
Acute gastrointestinal intestinal GVHD (aGI-GVHD) is a serious complication of allogeneic hematopoietic stem cell transplantation, and the intestinal microbiota is known to impact on its severity. However, an association between treatment response of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df4c8357b3a9282378e4c16512e977a0
https://doi.org/10.21203/rs.3.rs-2460097/v1
https://doi.org/10.21203/rs.3.rs-2460097/v1
